These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10255906)
1. Drug utilization review: a cost-effective method that doesn't tie up costly pharmacy staff time. John GW Cost Containment; 1982 Jun; 4(11):7-8. PubMed ID: 10255906 [No Abstract] [Full Text] [Related]
2. Pharmacy-laboratory interactions: a unique method to control antibiotic costs. Goff D; Thornton J Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600 [TBL] [Abstract][Full Text] [Related]
3. Cost-effective management of DUE (drug utilization evaluation) policy through a pharmacy clerkship. Julius HC Hosp Formul; 1993 Sep; 28(9):789-91. PubMed ID: 10128394 [TBL] [Abstract][Full Text] [Related]
8. A lab-pharmacy push to cut drug therapy costs. Rydzewski MM MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396 [No Abstract] [Full Text] [Related]
9. Antibiotic review performed by a pharmacy and therapeutics subcommittee. Klapp DL; Ramphal R QRB Qual Rev Bull; 1982 Jan; 8(1):15-9. PubMed ID: 6803205 [No Abstract] [Full Text] [Related]
10. An aminoglycoside policy directed at use and cost. Cynamon MH; Kallet KK; Zacher DE Hosp Formul; 1982 Jun; 17(6):811-2, 814. PubMed ID: 10256040 [No Abstract] [Full Text] [Related]
11. Monitoring antibiotic prescriptions can reduce use and cost of drugs. Douglas AS Mod Healthc; 1984 Oct; 14(13):106-7. PubMed ID: 10268397 [No Abstract] [Full Text] [Related]
12. Drug control program used to cut costs. Ollis LN; Britton HL Healthc Financ Manage; 1984 May; 38(5):98-100. PubMed ID: 10315555 [No Abstract] [Full Text] [Related]
13. Computerized billing as a tool for drug utilization. Pelissier NA Hosp Pharm; 1979 Dec; 14(12):711, 714-7. PubMed ID: 10309083 [TBL] [Abstract][Full Text] [Related]
14. Cost benefit of pharmacy audit and nonrestrictive antibiotic policy. Ware GJ; Ford DJ N Z Med J; 1993 Apr; 106(954):160. PubMed ID: 8479665 [No Abstract] [Full Text] [Related]
15. Antibiotic review: the experience of one pharmacy and therapeutics committee. Kiepert DR QRB Qual Rev Bull; 1979 Jan; 5(1):24-7. PubMed ID: 121376 [No Abstract] [Full Text] [Related]
17. DUE (drug usage evaluation) of ticarcillin and clavulanate potassium: determining appropriate and cost-effective therapeutic options. Lomaestro BM; Lesar TS Hosp Formul; 1988 Nov; 23(11):909. PubMed ID: 10312767 [TBL] [Abstract][Full Text] [Related]
18. Ongoing drug-use review through surveillance of serum antimicrobial-drug concentrations. Illsley SS Am J Hosp Pharm; 1988 Nov; 45(11):2380-1. PubMed ID: 3228097 [No Abstract] [Full Text] [Related]
19. Controlling moxalactam and cefotaxime use with a target drug program. Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791 [TBL] [Abstract][Full Text] [Related]
20. Possible savings with appropriate antibiotic prophylaxis. Hodgson T; Lannigan R; Mills D Can J Hosp Pharm; 1984; 37(3):95-7. PubMed ID: 10268247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]